Latest Non Dilutive Funding News

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Locksley Resources has made significant strides in its US critical minerals strategy, advancing proprietary antimony refining technology and expanding its Mojave Project landholding. The company also completed an oversubscribed capital raise to fund upcoming drilling and downstream processing initiatives.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.

First Au Limited has struck a deal granting AustChina Holdings an exclusive 19-month option to acquire its Eastern Victorian Goldfield Project, unlocking value from a non-core asset while sharpening focus on its African and Western Australian ventures.

IRIS Metals Limited has made substantial progress in its South Dakota lithium projects, completing critical drilling phases and expanding its land holdings through strategic acquisitions, supported by a recent $4.27 million capital raise.

Iondrive Limited has joined a €3.1 million European battery recycling consortium backed by a German government grant, aiming to establish a closed-loop supply chain using its innovative DES technology.

South Harz Potash Limited is progressing its transition to a dual-asset strategy, raising A$2.58 million to support expansion while adopting a cautious approach to its core German potash project amid market weakness.

Atlantic Lithium has revealed significant lithium-in-soil anomalies across its Rubino and Agboville licences in Côte d’Ivoire, alongside new spodumene pegmatite discoveries, signaling promising exploration potential in a largely underexplored region.

Latitude 66 has completed the sale of its 17.5% stake in the Greater Duchess Joint Venture to Carnaby Resources for A$6 million, eliminating debt and boosting funds for exploration.

Everest Metals has signed a strategic MOU with Arlington Innovation Partners to access U.S. government non-dilutive funding and partnerships, advancing its Mt Edon critical minerals project focused on rubidium and lithium.

Aguia Resources has locked in a R$6 million (A$1.7 million) bank loan to advance its Tres Estradas phosphate mine in Brazil, aiming for over 160,000 tonnes annual production by 2027. Initial sales agreements and a strong market backdrop set the stage for a potentially lucrative operation.